"What's Going on With My Ears?": Some Reflections on Managing Uncertainty in the Audiology Consultation.
Conclusions In this research note, we offer some reflections on this data set using a lens of uncertainty management theory and explore factors within the broader context that may contribute to the interactional features observed in the current study. Overall findings suggest the need for clinicians to be trained to embrace and address uncertainty rather than avoid it within challenging clinical encounters. PMID: 32569482 [PubMed - as supplied by publisher]
Publication date: Available online 10 July 2020Source: African Journal of Emergency MedicineAuthor(s): Tabitha Nadishani Meyer, Gareth Dudley Meyer, Hans Jurgen Hendriks
Publication date: September 2020Source: Molecular Immunology, Volume 125Author(s): David Ortega-Tirado, Esmeralda Ivonne Niño-Padilla, Aldo A. Arvizu-Flores, Carlos Velazquez, Clara Espitia, Carmen J. Serrano, José Antonio Enciso-Moreno, Adriana Sumoza-Toledo, Adriana Garibay-Escobar
Authors: Multani PK, Modi R, Basu S Abstract PURPOSE: To investigate recurrence patterns following anti-tubercular therapy (ATT) in different anatomical presentations of ocular tuberculosis (OTB). METHODS: Retrospective analysis of clinically diagnosed OTB patients divided anatomically into groups A (anterior + intermediate uveitis) and B (posterior + panuveitis). Recurrence was defined as reappearance of intraocular inflammation in a quiescent eye following completion of at least 6-months ATT. Anatomical sites of recurrence were compared to that of presentation. RESULTS: No significant difference in post-A...
CONCLUSION: Definite diagnosis of unilateral choroidal effusion was done. A comprehensive workup is needed to exclude potential malignant process. PMID: 32644830 [PubMed - as supplied by publisher]
One-fourth of the world ’s population is presumed latently infected with Mycobacterium tuberculosis (Cohen et al., 2019). The most common extrapulmonary manifestation of tuberculosis (TB) is tuberculous lymphadenitis (TBLA) (Holden et al., 2019a), often attributed to reactivation of latent infection (Fontanilla et al., 2 011; Mathiasen et al., 2019a). In countries with a low incidence of TB, the diagnosis may be difficult as the diseases is rare, delaying appropriate treatment (Mathiasen et al., 2019b).
More research emerged this week in potential support of using the tuberculosis vaccine Bacillus Calmette-Guerin (BCG) as a tool in the fight against coronavirus.
CONCLUSIONS: This is the ninth case of tuberculosis infection under immunotherapy and it underlines the need to consider infection risks in patients undergoing immunotherapy. An INF-γ release assay screening test should be considered an essential part of the pre-treatment work-up. PMID: 32636051 [PubMed - as supplied by publisher]
Publication date: Available online 10 July 2020Source: Saudi Journal of Biological SciencesAuthor(s): Ali Sami Dehyab, Mohd Fadzelly Abu Bakar, Mohamed Khalid AlOmar, Siti Fatimah Sabran
Publication date: Available online 9 July 2020Source: Clinical Epidemiology and Global HealthAuthor(s): Gyan Chandra Kashyap, Santosh Kumar Sharma, Shri Kant Singh
Conditions: HIV/AIDS; Tuberculosis Intervention: Behavioral: Choice Architecture Sponsors: Johns Hopkins University; University of Witwatersrand, South Africa; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting